Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01527604 · ClinicalTrials.gov registry record · NA
Effects of Avenanthramide-enriched Oats on Inflammation
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01527604 is a NA study that has completed, run by Tufts University. The registered enrollment target is 16 participants.
The verdict
NCT01527604, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The objective of this randomized, double-blinded, placebo-controlled, parallel trial is to determine whether consuming avenanthramide-enriched oats daily for 8 weeks on can improve biomarkers of inflammation in older, obese adults.
Interventions
- OTHER Avenanthramide-enriched oats
- OTHER Refined flour absent avenanthramides
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01527604
The ClinicalTrials.gov registry entry for NCT01527604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Avenanthramide-enriched oats is the first listed.
NCT01527604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01527604 about?
NCT01527604 is a clinical study titled "Effects of Avenanthramide-enriched Oats on Inflammation". The objective of this randomized, double-blinded, placebo-controlled, parallel trial is to determine whether consuming avenanthramide-enriched oats daily for 8 weeks on can improve biomarkers of inflammation in older, obese adults.
What is the current status of trial NCT01527604?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01527604?
The interventions under investigation include: Avenanthramide-enriched oats (OTHER), Refined flour absent avenanthramides (OTHER).
Who is sponsoring clinical trial NCT01527604?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.